MRP for 543 anti-cancer medicines slashed, effective from Nov 9
New Delhi: Drug price regulator NPPA on Wednesday, October 28, revised downward the maximum retail price of 543 anti-cancer medicines of different brands, effective November 9.
The revised list, released by the National Pharmaceutical Pricing Authority (NPPA), reflects information submitted by pharmaceutical companies up to October 27, 2026, and will be updated as and when manufacturers submit revised prices for non-scheduled anti-cancer drugs, said an official release by the Ministry of Chemicals and Fertilisers: Department of Pharmaceuticals.
Below is the list of 543 brands of anti cancer medicines with their revised MRP.
— Mohammed Zubair (@zoo_bear) October 28, 2026
Check the existing MRP vs Revised MRP. Credit goes to Ministry of Chemicals and Fertilisers, Karnataka. Hope this is done regularly across India. https://t.co/rEtDq7B9Hb
The price revision follows the NPPA’s October 17 announcement enforcing trade margin rationalisation on 137 non-scheduled anti-cancer drugs.
According to the official release, several key anti-cancer brands have seen steep price drops.
Here are the rates
- RPG Life Sciences Ltd’s Fulbreca (5 ml vial) will see its MRP reduced from Rs 26,072.16 to Rs 5,491.0
- Abbott Healthcare Pvt Ltd’s BEVACIZAB (4 ml vial) rate has been cut from Rs 21,767.70 to Rs 5,930.1.
- RPG Life Sciences’ Debrumab 60 mg (1 ml PFS) has been slashed from Rs 22,031.25 to Rs 5,941.0
- Hetero Healthcare Ltd’s FLUDANOX (vial) will now cost Rs 2,432.0, down from Rs 14,235.00.
- RPG Life Sciences’ Enuta (pack of 28 capsules) has been reduced from Rs 6,578.20 to Rs 2,232.0
- Dr Reddy’s Laboratories’ Azacytin (pack of 1) has been revised downwards from Rs 6,337.00 to Rs 1,495.0
- Natco Pharma’s Dasanat 20 (pack of 60 tablets) will now cost Rs 1,085.9, down from Rs 2,812.50
Get the latest updates in Hyderabad City News, Technology, Entertainment, Sports, Politics and Top Stories on WhatsApp & Telegram by subscribing to our channels. You can also download our app for Android and iOS.
This content is published by The Siasat Daily and has not been created or edited by Hello Headlines. View original
